Clinical Trial Update: CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery [Phase 4]

View source ↗

Summary

Phase 4 trial update on intensification with a CCR5 inhibitor to improve CD4+ T-cell recovery in HIV infections; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: University of California, San Diego | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2020-08-19